FDA
- Status: approved
🇺🇸 MDD diagnosis and Fluoxetine treatment in United States
MDD diagnosis and Fluoxetine treatment (MDD diagnosis and Fluoxetine treatment) regulatory status in United States.
Marketing authorisation
MDD diagnosis and Fluoxetine treatment in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is MDD diagnosis and Fluoxetine treatment approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for MDD diagnosis and Fluoxetine treatment in United States?
University of Pennsylvania is the originator. The local marketing authorisation holder may differ — check the official source linked above.